Colorectal neoplasia differentially expressed (CRNDE) was a newly characterized oncogene whose levels were elevated in various human malignancies and associated with clinicopathological features and a poor prognosis, such as colorectal cancer, lung cancer, breast cancer, hepatocellular carcinoma, and so forth. This evidence concerns the gene CRNDE and breast cancer.